Reuters logo
BRIEF-Tonix Pharmaceuticals Q3 loss per share $0.77
November 7, 2017 / 12:18 PM / 11 days ago

BRIEF-Tonix Pharmaceuticals Q3 loss per share $0.77

Nov 7 (Reuters) - Tonix Pharmaceuticals Holding Corp

* Tonix Pharmaceuticals reports third quarter 2017 financial results and provides programs update

* Q3 loss per share $0.77

* Tonix Pharmaceuticals Holding Corp - ‍at September 30, 2017, Tonix had cash and cash equivalents of $29.3 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below